• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension

    High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension

    JournalISSN 1120-9879eISSN 1179-1985中科院 医学 3区

    年发文量

    研究主题

    论文(1552)

    排序
    1Influence of Systolic Blood Pressure and Pulse Pressure on Heart Failure Risk in Elderly Treated Hypertensive Patients
    Francesca Coccina,Chiara Cuccurullo, Nelson Anzoletti, Ettore Porreca,Sante D. Pierdomenico

    It is unclear whether systolic blood pressure (BP) and pulse pressure (PP), either clinic or ambulatory, differ in their ability to predict heart failure (HF) in elderly hypertensive patients. To evaluate the influence of clinic and ambulatory systolic BP and PP on HF risk in elderly treated hypertensive subjects. In this retrospective study, we assessed 1314 individuals (aged ≥ 65 years) undergoing clinic and ambulatory BP measurement. Association of BP parameters with HF was investigated by univariable and multivariable Cox regression analyses. Differences between competing models were assessed by receiver operating characteristic curve (ROC) analysis, Akaike’s Information Criterion (AIC) and Schwarz Bayesian Information Criterion (BIC). During the follow-up (7.0 ± 4.0 years), 126 HF events occurred. After adjustment for covariates, clinic systolic BP and PP were not significantly associated with HF risk, whereas daytime systolic BP, daytime PP, nighttime systolic BP and nighttime PP were, showing a hazard ratio (95

    2026
    引用
    AI阅读
    加入学术空间
    2Correction: Interventional Treatment of Arterial Hypertension in the Modern Era: an Updated Review
    Yusuf Ziya Şener,Costantino Mancusi,Alexandr Ceasovschih,Andrej Belančić,Ariadni Menti,Christina Antza, Diana Ferrao, Jelena Petrović,Justine Huart,Karel Lábr,Ilaria Fucile,Marijana Vučković,
    2026
    引用
    AI阅读
    加入学术空间
    3A Practical Treatment Platform Version 3.0 for Using Angiotensin Receptor Blocker-Based Single-Pill Combinations in Patients with Hypertension
    Giuliano Tocci,Michel Burnier,Alejandro de la Sierra,Guido Grassi,Krzysztof Narkiewicz,Reinhold Kreutz,Konstantinos Tsioufis,Massimo Volpe

    Elevated blood pressure (BP) is the leading cause of cardiovascular disease and a major contributor to mortality, affecting almost one third of the adult population worldwide. Despite strong scientific evidence, guidelines and multiple therapeutic options, many patients remain undertreated or uncontrolled, largely due to poor medication adherence and medical inertia. Complexity of multi-pill regimens contributes significantly to non-adherence, whereas single-pill combinations (SPCs) improve adherence and persistence, accelerate BP control, and promote better long-term outcomes than multiple combinations. Appropriate selection of SPC in individual hypertensive patients may be a difficult though very important task for physicians. Thus, development of tools that may facilitate use of SPC in clinical practice is desirable. Among renin–angiotensin system blockers, olmesartan (OM) has demonstrated sustained efficacy, favourable tolerability, both as monotherapy and in SPCs with amlodipine and/or hydrochlorothiazide, which are available in multiple dosages. The present OM-based platform builds on earlier frameworks and incorporates guidelines’ updates complemented by a systematic review of available literature. This “3.0” proposal expands patient categorization to include comorbidities or complications often overlooked in clinical practice guidelines, providing a practical, evidence-based approach to support individualized hypertension management complementing guideline recommendations. The Olmesartan-Based Treatment Platform 3.0 provides a practical framework for the individualized management of hypertension. Following phenotypic characterization, treatment is tailored according to cardiovascular risk, hypertension-mediated organ damage, comorbidities, and out-of-office blood pressure profile, supporting evidence-based selection and intensification of olmesartan-based therapies to achieve optimal blood pressure control and cardiovascular protection.

    2026
    引用
    AI阅读
    加入学术空间
    4Arterial Hypertension and Kidney Function Decline in Systemic Sclerosis and Sjögren’s Disease: A Longitudinal Comparative Study
    Antonietta Gigante,Chiara Pellicano, Emanuele Grilli, Elena Maria Di Virgilio,Angelica Gattamelata,Francesco Iannazzo,Rosario Cianci,Edoardo Rosato,Roberta Priori

    Renal involvement is increasingly recognized in Systemic Sclerosis (SSc) and Sjögren’s Disease (SjD). However, the association between hypertension and renal function decline in these conditions remains poorly understood. to compare renal function changes over time in patients with SSc and SjD; identify factors associated with clinically relevant renal function decline; and to evaluate whether the association between hypertension and renal function differs between the two diseases. We retrospectively analyzed patients with SSc and SjD, followed for up to 3 years. Renal function was assessed using estimated glomerular filtration rate (eGFR). Clinically relevant renal decline was defined as a reduction in eGFR ≥10 ml/min Multivariable logistic regression identified factors associated with renal function decline, including the interaction between diagnosis and hypertension. A total of 238 patients were included (114 with SSc and 124 with SjD), with a median age of 55 years (IQR 45–65) in SSc and 57 years (IQR 48–66) in SjD. At baseline, SSc patients showed higher eGFR compared to SjD, but experienced a greater decline over time (median −6 vs −2.1 ml/min, p < 0.05). Overall, 33.8

    2026
    引用
    AI阅读
    加入学术空间
    5Differences in Office and Ambulatory Pulse Wave Analysis in Patients with White Coat Hypertension and Other Hypertension Phenotypes
    Ann-Kathrin Carolin Schäfer, Eva Maria Nuhn,Stephan Lüders, Clemens Grupp,Manuel Wallbach,Michael Johann Koziolek

    Increased arterial stiffness is a sign of vascular damage; therefore, assessing it is crucial for evaluating cardiovascular risk. Arterial stiffness parameters such as pulse wave velocity (PWV) and augmentation index (at heart rate 75 bpm, AIX@75) were shown to correlate directly with blood pressure (BP). Since these parameters may consequently be altered in patients with white coat effect (WCE), this study examined differences in office and 24h measurements of these parameters across various BP phenotypes. In this multicenter cross-sectional study, conducted between 2018 and 2023 at three nephrology clinics, office and 24h BP measurements and pulse wave analysis (PWA) of 208 patients were examined. 189 patients were included; 48 were diagnosed with controlled hypertension (HTN), 63 with uncontrolled HTN, 22 with a masked HTN phenotype, 30 with WCE, of whom 11 had white coat HTN (WCH) and 19 had white coat uncontrolled HTN (WCUH), and 26 had normal BP. By definition, patients with WCE had significantly higher office peripheral and aortic BP than the respective 24h values (p<0.0001 each). Their AIX@75 was significantly higher on office (32.7±11.4

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 1552 篇论文

    高被引作者

    作者引用发文
    Massimo Volpe1413159
    Claudio Ferri115771
    Claudio Borghi114068
    Guido Grassi108168
    Maria Lorenza Muiesan102751
    Massimo Salvetti102143
    Giuliano Tocci96094
    Enrico Agabiti Rosei92023
    Rizzoni Damiano89841
    Giuseppe Mancia76944

    高产作者

    作者引用发文
    Massimo Volpe1413159
    Giuliano Tocci96094
    Claudio Ferri115771
    Guido Grassi108168
    Claudio Borghi114068
    Maria Lorenza Muiesan102751
    Franco Veglio53846
    Giuseppe Mancia76944
    Massimo Salvetti102143
    Stefano Taddei66741

    相关期刊

    Blood pressure
    Journal of clinical hypertension
    Journal of human hypertension
    Blood pressure monitoring
    Current cardiology reviews
    Clinical hypertension
    Clinica e Investigacion en Arteriosclerosis
    Hipertensión y Riesgo Vascular
    Arterial Hypertension
    INTERNATIONAL JOURNAL CARDIOLOGY HYPERTENSION